Girnius, NomedaDavis, Roger J.2022-08-232022-08-232016-02-082016-02-19Cancer Cell. 2016 Feb 8;29(2):131-3. doi: 10.1016/j.ccell.2016.01.008. <a href="http://dx.doi.org/10.1016/j.ccell.2016.01.008">Link to article on publisher's site</a>1535-6108 (Linking)10.1016/j.ccell.2016.01.00826859448https://hdl.handle.net/20.500.14038/28290Smac mimetics (SMs), a class of drugs that can promote tumor cell death, represent a potential therapeutic strategy for the treatment of cancer. In this issue of Cancer Cell, Lalaoui et al. (2016) report that SM efficacy can be potently increased by inhibition of the p38alpha MAPK/MK2 signaling pathway.en-USBiochemistryCell BiologyCellular and Molecular PhysiologyMolecular BiologyJournal Articlehttps://escholarship.umassmed.edu/davis/208179702davis/20